Benin: ABMed Lifts Quarantine on Two Medications
Two medications produced by the Pharmaquick laboratory: Diclofenac 50 mg and Amoxicillin 500 mg had previously been quarantined in Benin due to irregularities.
On May 26, 2025, the Beninese Agency of Medicine (ABMed) issued a statement announcing the lifting of the suspension. The medications can now be redistributed and prescribed safely.
The National Agency for Quality Control of Health Products and Water (ANCQ) confirmed that the detected irregularities do not affect the intrinsic quality of the products.
Wholesale distributors and pharmacies are authorized to resume distribution. However, they must remove from their stock the blister packs containing the non-compliant batches.
Youssounon CHABI, director of ABMed, personally encouraged all stakeholders to resume the normal use of these medications, taking care to eliminate the problematic batches.
Related Articles
August 1, 2026: “We must learn from our journey to build a better future,” Kamel Ouassagari
Cotonou: FAGACE ready to support the financing of the city’s structuring projects
End of the work of the ECOWAS Parliament Joint Commission in Cotonou: Kamel Ouassagari calls for better implementation of community texts.
Abomey-Calavi: a woman in court over the disappearance of a rental vehicle.
Comments
Comments load when you reach this section.